To Evaluate Safety, Pharmacokinetics and Pharmacodynamics of MEDI6012 in Subjects With Stable Coronary Artery Disease
Clinical trial NCT02601560 · COMPLETED
Trial details
- NCT number
- NCT02601560
- Sponsor
- MedImmune LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-03
- Primary completion
- 2016-08-20
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.